Moreover, KLF6-expressing GBMs often express a dominant-negative splice variant (KLF6-SV1), which is mislocalized to the cytoplasm and antagonizes the tumor suppressor activity of the full-length KLF6 protein (KLF6-FL) [92]. Here, KLF6 is linked to neoplasm.